Eczematous reaction to intravenous immunoglobulin: An alternative cause of eczema

JAMA Dermatology

Volumn 150, Issue 10, 2014, Pages 1120-1122

  Miyamoto, Julia ^a,b   Böckle, Barbara C ^b   Zillikens, Detlef ^c   Schmidt, Enno ^c   Schmuth, Matthias ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; EMOLLIENT AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; SIMVASTATIN; TAMSULOSIN;

ADVERSE OUTCOME; AGED; BASEMENT MEMBRANE; CASE REPORT; ECZEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN DEPOSITION; LETTER; LYMPHOCYTIC INFILTRATION; MEDICAL HISTORY; NONHUMAN; PERIPHERAL NEUROPATHY; SKIN BIOPSY; SKIN EDEMA; CHEMICALLY INDUCED; DRUG ERUPTIONS; MALE;

AGED; DRUG ERUPTIONS; ECZEMA; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE;

EID: 84908032025     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.109     Document Type: Letter

References (6)

1. Endo Y, Tsujioka K, Tanioka M, et al. Bullous dermatosis associated with IgG antibodies specific for desmocollins. Eur J Dermatol. 2010;20(5):620-625.
2. Müller R, Heber B, Hashimoto T, et al. Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol. 2009;34(8):898-903.
3. Gerstenblith MR, Antony AK, Junkins-Hopkins JM, Abuav R. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy. J AmAcad Dermatol. 2012;66(2):312-316.
4. Sarmiento E,Micheloud D, Carbone J. Complement consumption associated with eczematous cutaneous reaction during infusions of high doses of intravenous immunoglobulin. Br J Dermatol. 2004;151(3):721.
5. Osei A, Uttenreuther-Fischer MM, Lerch H, Gaedicke G, Fischer P. Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin. Arthritis Rheum. 2000;43(12):2722-2732.
6. Leucht S, Uttenreuther-Fischer MM, Gaedicke G, Fischer P. The B cell superantigen-like interaction of intravenous immunoglobulin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy. Clin Immunol. 2001;99(1):18-29.